Quibim
PrivateLast Round
Series A
Jan 28, 2025
Total Funding Raised
$61.71M
Company Overview
Quibim is a health technology company that develops artificial intelligence-powered solutions for medical imaging analysis to extract quantitative biomarkers for diagnostics and drug development.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quibim Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Quibim Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2025 | ||||
| Seed | Jul 21, 2020 | ||||
| Grant | Dec 1, 2018 | ||||
| Grant | Feb 1, 2018 |
Quibim Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series A |
| Amadeus Capital Partners | Series A, Seed |
| Partech | Seed, Series A |
| Partech | Series A |
| Leadwind | Series A |
| GED Capital | Series A |
| Build Collective | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
Launched AI-QUAL for automated prostate MRI image quality assessment.
- Jan 28, 2025
$50M Series A round completed.
Quibim Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quibim's valuation, stock price, and market status.